Table 2.
Age (years) | Men (SD; range) | Women (SD; range) | Total (SD; range) | P value* |
---|---|---|---|---|
16–29 | 0.52 (0.74; 0–5) | 0.72 (0.91; 0–7) | 0.63 (0.85; 0–7) | <0.001 |
30–44 | 0.86 (1.15; 0–8) | 1.18 (1.31; 0–8) | 1.05 (1.26; 0–8) | <0.001 |
45–59 | 1.72 (1.69; 0–11) | 2.05 (1.82; 0–12 | 1.91 (1.77; 0–12) | <0.001 |
60–74 | 3.26 (2.24; 0–17) | 3.49 (2.27; 0–14)) | 3.40 (2.26; 0–17) | 0.023 |
75+ | 5.02 (2.66; 0–14) | 5.01 (2.65; 0–18) | 5.02 (2.66; 0–18) | 0.974 |
Total | 1.72 (2.04; 0–17) | 2.03 (2.13; 0–18) | 1.90 (2.10; 0–18)a | <0.001 |
SD standard deviation, COPD chronic obstructive pulmonary disease
*P value calculated for the difference in mean between men and women
aAs a reference: in a previous study in patients with COPD (aged ≥40 years) using the same general practice database, we observed an average number of 3.0 chronic comorbid diseases33